Latest Complete blood count Stories
California Institute of Technology White blood cells, or leukocytes, are the immune system's warriors. So when an infection or disease attacks the body, the system typically responds by sending more white blood cells into the fray. This means that checking the number of these cells is a relatively easy way to detect and monitor such conditions. Currently, most white blood cell counts are performed with large-scale equipment in central clinical laboratories. If a physician collects blood...
UNION CITY, Calif., Nov. 13, 2012 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Don Wood, chief operations officer , will participate in Sidoti & Company's inaugural one-on-one conference on Monday, November 19, 2012. The conference will be held at the Grand Hyatt Hotel in New York City. About AbaxisAbaxis develops, manufactures, markets and sells portable blood analysis systems...
UNION CITY, Calif., Nov. 7, 2012 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Don Wood, chief operations officer , will present at the Stephens Fall Investment Conference on Wednesday, November 14, 2012 at 8:45 a.m. ET. The conference will be held at The New York Palace Hotel in New York City. About AbaxisAbaxis develops, manufactures, markets and sells portable blood analysis...
October is Breast Cancer awareness month and women need to be aware of blood markers listed below. Monitor every one of them on My Blood works App for iPhone, iPad and iTouch. (PRWEB) October 23, 2012 Before, during and after treatment for breast cancer, the physician will order blood tests. These tests check to see whether the blood has normal amounts of various types of blood cells. The cancer and related treatments like chemotherapy and radiation can reduce important blood cell levels...
UNION CITY, Calif., Sept. 13, 2012 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Severson, chairman and chief executive officer, will present at the UBS Global Life Sciences Conference on Wednesday, September 19, 2012 at 10:00 a.m. ET. The conference will be held at the Grand Hyatt New York Hotel in New York City. About AbaxisAbaxis develops, manufactures, markets and sells...
UNION CITY, Calif., Sept. 4, 2012 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Severson, chairman and chief executive officer, will present at the CL King's 10th Annual Best Ideas Conference 2012 on Wednesday, September 12, 2012 at 12:40 p.m. ET. The conference will be held at the Omni Berkshire Place Hotel in New York City. About AbaxisAbaxis develops, manufactures, markets...
Connie K. Ho for redOrbit.com – Your Universe Online Dressed in a white coat, a physician wrapped a piece of gauze around the arm of a female wearing a black shirt. The female was tense and anxious, sitting patiently as vials were attached to her arm. These actions could possibly decide the next step of her treatment. This is a typical scene at Pluristem Therapeutics, an Israeli-based company that focuses on placenta-based cell therapies. Pluristem Therapeutics developed this...
UNION CITY, Calif., Aug. 8, 2012 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Severson, chairman and chief executive officer, will present at the Canaccord Genuity 32(nd) Annual Growth Conference on Wednesday, August 15, 2012 at 8:00 a.m. ET. The conference will be held at the InterContinental Boston Hotel in Boston, MA. About AbaxisAbaxis develops, manufactures, markets and...
Eltrombopag, a drug that was designed to stimulate production of platelets from the bone marrow and thereby improve blood clotting, can raise blood cell levels in some people with severe aplastic anemia who have failed all standard therapies. About one-third of aplastic anemia cases do not respond to standard therapy, a combination of immune-suppressing drugs. Although bone marrow stem cell transplantation is an option for some, patients without a matched donor have few treatment options....
UNION CITY, Calif., May 29, 2012 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Severson, chairman and chief executive officer , will present at the Jefferies 2012 Global Healthcare Conference on Tuesday, June 5, 2012 at 9:00 a.m. ET. The conference will be held at the Grand Hyatt in New York City. About Abaxis Abaxis develops, manufactures, markets and sells portable...
